BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/23/2016 6:33:00 PM | Browse: 1109 | Download: 1159
Publication Name World Journal of Gastroenterology
Manuscript ID 26804
Country/Territory United Kingdom
Received
2016-04-27 10:28
Peer-Review Started
2016-04-27 11:29
To Make the First Decision
2016-05-30 09:22
Return for Revision
2016-05-30 14:56
Revised
2016-06-10 01:07
Second Decision
2016-06-23 17:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-07-06 18:53
Articles in Press
2016-07-06 18:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-08-12 17:35
Publish the Manuscript Online
2016-08-24 10:09
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
Manuscript Source Invited Manuscript
All Author List Alexandra R Lewis, Juan W Valle and Mairead G McNamara
Funding Agency and Grant Number
Corresponding Author Dr. Mairead G McNamara, The Christie NHS Foundation Trust, 550 Wilmslow Road, M20 4BX Manchester, United Kingdom. mairead.mcnamara@christie.nhs.uk
Key Words Pancreatic; Cancer; Liquid biopsy; Circulating; Tumour; Cells; Circulating tumour DNA
Core Tip Pancreatic cancer is a difficult disease to diagnose and treat. Persistently poor outcomes mean that new biomarkers of disease and treatments are required. Circulating tumour cells and circulating tumour DNA have been investigated as liquid biopsies in pancreatic cancer. Sensitivity is variable but speci?ficity promising. The most effective platform and most informative biomarkers are yet to be identified. There are many potential roles for this technology in the management of patients with pancreatic cancer, including screening, diagnosis, prognosis and monitoring of treatment efficacy; however based on current available evidence they are not yet ready for routine clinical practice.
Publish Date 2016-08-24 10:09
Citation Lewis AR, Valle JW, McNamara MG. Pancreatic cancer: Are “liquid biopsies” ready for prime-time? World J Gastroenterol 2016; 22(32): 7175-7185
URL http://www.wjgnet.com/1007-9327/full/v22/i32/7175.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i32.7175
Full Article (PDF) WJG-22-7175.pdf
Full Article (Word) WJG-22-7175.doc
Manuscript File 26804-Review.doc
Answering Reviewers 26804-Answering reviewers.pdf
Audio Core Tip 26804-Audio core tip.wav
Conflict-of-Interest Disclosure Form 26804-Conflict-of-interest statement.pdf
Copyright License Agreement 26804-Copyright assignment.pdf
Peer-review Report 26804-Peer-review(s).pdf
Scientific Misconduct Check 26804-Scientific misconduct check.pdf
Scientific Editor Work List 26804-Scientific editor work list.pdf